As has become tradition in the pharma and biotech world, 2024 kicked off with a bang as experts from around the globe gathered in San Francisco for the 42nd annual JP Morgan Health Conferen
Generative AI – large language models, or LLMs, like ChatGPT – has the potential to revolutionise almost any knowledge industry, and pharma is no exception.
One of the most compelling things about artificial intelligence chat technologies like ChatGPT and AIChat is their ability to generate human-like responses - but that may
On Tuesday afternoon, 23rd May, pharmaphorum headed over to The Royal Society of Medicine to learn more about how the pharmaceutical industry goes about securing market access to medicines
Novartis has struck another deal to build its position in radiopharmaceuticals, agreeing to pay $1 billion upfront for radioligand therapy (RLT) developer Mariana Oncology
It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.
